Skip to main content
. 2012 Nov 29;8(11):e1003081. doi: 10.1371/journal.pgen.1003081

Figure 3. Heart-specific inactivation of dJun and Vrille transcription factors improve heart performance.

Figure 3

Cardiac imaging was performed on w/Y;UAS-mitoGFP/+;Hand-GS/+ (+), w/Y;UAS-mitoGFP/+;Hand-GS/UAS-dJun-IR (dJun-IR), w/Y;UAS-mitoGFP/UAS-vrille_IR; Hand-GS/+ (vrille-IR) and w/Y;UAS-mitoGFP/UAS-vrille; Hand-GS/+ (vrille OE) male flies treated with RU 486 (100 µg/ml of food) during adulthood. (A) Representative 10 sec M-Modes of 45-day-old flies. (B) End Diastolic Diameter (EDD, µm) in 10-day-old and 45-day-old flies. Significant differences are indicated: * p<5.10−2, ** p<5.10−3. (C,D,E) Heart Period (ms) and Arrhythmicity Index. Significant differences with control (+) flies of the same age are indicated: * p<5.10−2, ** p<5.10−3. All values are means (±SEM). +/3 days: n = 13; +/10 days: n = 26; +/30 days: n = 34; +/45 days: n = 34; dJun-IR/3 days: n = 11; dJun-IR/10 days: n = 10; dJun-IR/30 days: n = 8; dJun-IR/45 days: n = 14; vrille-IR/10 days: n = 22; vrille-IR/30 days: n = 29; vrille-IR/45 days: n = 38; vrille OE/10 days: n = 12; vrille OE/10 days: n = 3; + vrille OE/30 days: n = 15; vrille OE/45 days: n = 12.